Different effects of vinblastine on the polymerization of isotypically purified tubulins from bovine brain

Investigational New Drugs

Volumn 21, Issue 1, 2003, Pages 3-13

  Khan, Israr A ^a,b   Ludueña, Richard F ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Alpha Diagnostics International Inc   (United States)

Author keywords

Microtubules; Tubulin; Tubulin isotypes; Vinblastine; Vinca alkaloids

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2; PROTEIN SUBUNIT; TAU PROTEIN; TUBULIN; VINBLASTINE; VINCA ALKALOID;

ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN; CATTLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; MICROTUBULE ASSEMBLY; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN INTERACTION; TIME SERIES ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRAIN CHEMISTRY; CATTLE; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; POLYMERS; PROTEIN ISOFORMS; TAU PROTEINS; TIME FACTORS; TUBULIN; VINBLASTINE;

EID: 0038353464     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022946305242     Document Type: Article

References (49)

1. Dustin P: Microtubules, 2nd edn. Springer-Verlag, Berlin, 1984
2. Ludueña RF, Shooter EM, Wilson: Structure of the tubulin dimer. J Biol Chem 252: 7006-7014, 1977
3. Ludueña RF: Multiple forms of tubulin: different gene products and covalent modifications. Int Rev Cytol 178: 207-275, 1998
4. Wilson L, Jordan MA: Pharmacological probes of microtubule function. In: Hyams JS, Lloyd CW (eds) Microtubules. Wiley-Liss, New York, 1994, pp 59-83
5. Wordeman L, Mitchison T: Dynamics of microtubule assembly in vivo. In: Hyams JS, Lloyd CW (eds) Microtubules. Wiley-Liss, New York, 1994, pp 287-301
6. Panda D, Miller HP, Banerjee A, Ludueña RF, Wilson L: Microtubule dynamics in vitro are regulated by the tubulin isotype composition. Proc Natl Acad Sci USA 91: 11358-11362, 1994
7. Derry WB, Wilson L, Khan IA, Ludueña RF, Jordan MA: Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified β-tubulin isotypes. Biochemistry 36: 3554-3562, 1997
8. Banerjee A, Roach MC, Trcka P, Ludueña RF: Increased microtubule assembly in bovine brain tubulin lacking the type III isotype of β-tubulin. J Biol Chem 265: 1794-1799, 1990
9. IV tubulin dimers from bovine brain. J Biol Chem 267: 5625-5630, 1992
10. Khan IA, Tomita I, Mizuhashi F, Ludueña RF: Differential interaction of tubulin isotypes with the antimitotic compound IKP-104. Biochemistry 39: 9001-9009, 2000
11. Lobert S, Frankfurter A, Correia JJ: Energetics of Vinca alkaloid interactions with tubulin isotypes: implications for drug efficiency. Cell Motil Cytoskeleton 39: 107-121, 1998
12. Laing N, Dahllöf B, Hartley-Asp B, Ranganathan S, Tew KD: Interaction of estramustine with tubulin isotypes. Biochemistry 36: 871-878, 1997
13. Banerjee A, Ludueña RF: Distinct colchicine binding kinetics of bovine brain tubulin lacking the type III isotype of β-tubulin. J Biol Chem 266: 1689-1691, 1991
14. Banerjee A, Ludueña RF: Kinetics of colchicine binding to purified β-tubulin isotypes from bovine brain. J Biol Chem 267: 13335-13339, 1992
15. Toso RJ, Jordan MA, Farrell KW, Matsumoto B, Wilson L: Kinetic stabilization of microtubule dynamic instability in vitro by vinblastine. Biochemistry 32: 1285-1293, 1993
16. Dhamodharan P, Jordan MA, Thrower D, Wilson L, Wadsworth P: Vinblastine suppresses dynamics of individual microtubules in living interphase cells. Mol Biol Cell 6: 1215-1229, 1995
17. Jordan MA, Margolis RL, Himes RH, Wilson L: Identification of a distinct class of vinblastine binding sites on microtubules. J Mol Biol 187: 61-73, 1986
18. Singer WD, Jordan MA, Wilson L, Himes RH: Binding of vinblastine to stabilized microtubules. Mol Pharmacol 36: 366-370, 1989
19. Wilson L, Jordan MA, Morse A, Margolis RL: Interaction of vinblastine with steady-state microtubules in vitro. J Mol Biol 159: 125-149, 1982
20. Hamel E: Interactions of tubulin with small ligands. In: Avila J (ed.) Microtubule Proteins. CRC Press, Boca Raton, 1990, pp 89-191
21. Bensch KG, Malawista SE: Microtubular crystals in mammalian cells. J Cell Biol 40: 95-107, 1969
22. Warfield RKN, Bouck GB: Microtubule-macrotubule transition: intermediates after exposure to the mitotic inhibitor vinblastine. Science 186: 1219-1220, 1974
23. Himes RH: Interaction of the catharanthus (Vinca) alkaloids with tubulin and microtubules. Pharmac Ther 51: 257-267, 1991
24. Schochet SS Jr, Lambert PW, Earle KM: Neuronal changes induced by intrathecal vincristine sulfate. J Neuropathol Exp Neurol 27: 645-658, 1968
25. 3H-labeled vinblastine binding to vinblastine-tubulin crystals. J Mol Biol 121: 255-268, 1978
26. Fellous A, Francon J, Lennon AM, Nunez J: Microtubule assembly in vitro. Purification of assembly-promoting factor. Eur J Biochem 78: 167-174, 1977
27. III-tubulin. Biochemistry 35: 3704-3711, 1996
28. Lowry OH, Rosebrough NH, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951
29. Rai SS, Wolff J: Localization of the vinblastine-binding site on β-tubulin. J Biol Chem 271: 14707-14711, 1996
30. Timasheff SN, Andreu JM, Na GC: Physical and spectroscopic methods for the evaluation of the interaction of antimitotic agents with tubulin. Pharmac Ther 52: 191-210, 1991
31. Correia JJ: Effects of antimitotic agents on tubulin-nucleotide interactions. Pharmac Ther 52: 127-147, 1991
32. Ludueña RF, Roach MC: Tubulin sulfhydryl groups as probes and targets for antimitotic and antimicrotubule agents. Pharmac Ther 49: 13-152, 1991
33. Morgan JL, Spooner BS: Immunological detection of microtubule poison-induced conformational changes in tubulin. J Biol Chem 258: 13127-13133, 1983
34. Prakash V, Timasheff SN: The interaction of vincristine with calf brain tubulin. J Biol Chem 258: 1689-1697, 1983
35. Lee JC, Harrison D, Timasheff SN: Interaction of vinblastine with calf brain microtubule protein. J Biol Chem 250: 9276-9282, 1975
36. Cleveland DW, Hwo SY, Kirschner MW: Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J Mol Biol 116: 227-247, 1977
37. Scheele RB, Borisy GG: In vitro assembly of microtubules. In: Roberts K, Hyams J (eds) Microtubules. Academic Press, London, 1979, pp 175-254
38. Ludueña RF, Fellous A, McManus L, Jordan MA, Nunez J: Contrasting roles of tau and microtubule-associated protein 2 in the vinblastine-induced aggregation of brain tubulin. J Biol Chem 259: 12890-12898, 1984
39. Schwarz PM, Liggins JR, Ludueña RF: β-Tubulin isotypes purified from bovine brain have different relative stabilities. Biochemistry 37: 4687-4692, 1998
40. Banerjee A, Ludueña RF: Kinetics of colchicine binding to purified β-tubulin isotypes from bovine brain. J Biol Chem 267: 13335-13339, 1992
41. Lobert S, Frankfurter A, Correia JJ: Binding of vinblastine to phosphocellulose-purified and αβ-class III tubulin: the role of nucleotides and β-tubulin isotypes. Biochemistry 34: 8050-8060, 1995
42. Na GC, Timasheff SN: Stoichiometry of the vinblastine-induced self-association of calf brain tubulin. Biochemistry 19: 1347-1354, 1980
43. Na GC, Timasheff SN: Interaction of vinblastine with calf brain tubulin: multiple equilibria. Biochemistry 25: 6214-6222, 1986
44. Prasad V, Jordan MA, Ludueña RF: Temperature sensitivity of vinblastine-induced tubulin polymerization in the presence of microtubule-associated proteins. J Prot Chem 11: 509-515, 1992
45. Fellous A, Prasad V, Ohayon R, Jordan MA, Ludueña RF: Removal of the projection domain of microtubule-associated protein 2 alters its interaction with tubulin. J Prot Chem 13: 381-391, 1994
46. IVa-tubulin isotypes in human prostate carcinoma cells as a result of estramustine resistance. Cancer Res 56: 2584-2589, 1996
47. Haber M, Burkhart CA, Regl DL, Madafiglio J, Norris MD, Horwitz SB: Altered expression of Mβ2, the class II β-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance. J Biol Chem 270: 31269-31275, 1995
48. Dumontet C, Duran GE, Steger KA, Beketic-Oreskovic L, Sikic BI: Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (taxol). Cancer Res 56: 1091-1097, 1996
49. Jaffrézou JP, Dumontet C, Derry WB, Durán G, Chen G, Tsuchiya E. Wilson L, Jordan MA, Sikic BI: Novel mechanism of resistance to paclitaxel (taxol) in human K562 leukemia cells by combined selection with PSC833. Oncol Res 7: 517-527, 1995